AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Hikem Tablet

Prescription Icon
Prescription Required

Marketer

Bioceutics Inc

Salt Composition

Hydroxychloroquine (200mg)

Overview Hikem Tablet

Autoimune disorders like rheumatoid arthritis and lupus are treated with Arthalin tablets, which mitigate disease advancement and alleviate associated pain, inflammation, and redness. Additionally, Arthalin improves blood sugar management in type 2 diabetes patients. To minimize gastrointestinal distress, Arthalin should be taken with meals, consistently at the same time daily for optimal efficacy. Continue the prescribed dosage as directed, even if symptoms improve. Common side effects include nausea, vomiting, diarrhea, and stomach pain; persistent or worsening side effects warrant medical attention. Your physician can offer strategies to mitigate these. Prior to commencing Arthalin, inform your doctor of any pre-existing heart, kidney, or liver conditions, and all other medications. Use is contraindicated with visual disturbances and prolonged pediatric use. Regular vision checks may be recommended during treatment. Pregnant or breastfeeding individuals should seek medical counsel before use.

Primary Ingredients of Hikem Tablet

The information is unavailable.

Uses of Hikem Tablet

Management of type 2 diabetes | Rheumatoid arthritis management | Systemic lupus erythematosus (SLE) therapy

Major Benefits of Hikem Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Hikem Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Hikem Tablet:

  • Skin rash
  • Itching
  • Affect lability
  • Abdominal pain
  • Blurred vision
  • Headache
  • Decreased appetite
  • Diarrhea
  • Vomiting
  • Nausea

How to use Hikem Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Hikem Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Hikem Tablet works:

Arthalen tablets function as a disease-modifying antirheumatic medication (DMARD), mitigating joint inflammation and pain by reducing excessive immune system activity. This action helps to curb the underlying disease's advancement. Furthermore, evidence indicates that the active ingredient may enhance insulin responsiveness and pancreatic beta-cell performance, potentially leading to better blood sugar management in individuals with type 2 diabetes.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of Hikem Tablet with alcohol requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnant women can generally use Hikem Tablet without safety concerns. Research indicates minimal to nonexistent hazard to the fetus.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and Hikem Tablet use are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Hikem Tablet side effects, including potential vision problems.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Hikem Tablets, as dosage modification may be necessary. Physician consultation is advised. This medication has potential ocular effects; routine eye examinations are recommended during treatment.

LiverLiverCAUTION

Patients with hepatic impairment should use Hikem Tablet judiciously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Hikem Tablet :

Should you forget a Hikem Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Hikem Tablet

LabelValue
Type of Compound 4-Aminoquinoline-based compound
Potential for Dependence None.
Type of Treatment Pain relievers

FAQs on Hikem Tablet

Clinical trials are evaluating Hikem Tablet's potential to prevent and treat COVID-19. Preclinical laboratory research indicates some antiviral activity against the novel coronavirus. Nevertheless, conclusive evidence of Hikem Tablet's efficacy against this virus remains pending.
India's COVID-19 task force (under the ICMR) advises Hikem Tablet solely for coronavirus prevention within specific high-risk groups (individuals with substantial virus exposure risk) or emergencies. Prophylactic use is suggested for asymptomatic healthcare personnel treating suspected or confirmed COVID-19 patients, and asymptomatic household members of confirmed cases.
We don't carry Hikem Tablets. If you believe you may have COVID-19, seek immediate medical attention and adhere to your physician's instructions. Never use Hikem Tablets without a doctor's prescription. This medication is for use only as directed by a licensed medical professional.
Coronavir prevention using Hikem Tablets is advised solely for specific high-risk populations or urgent circumstances. Adherence to the physician's prescribed dosage, schedule, and treatment length is mandatory.
Hikem tablets are for oral administration. To minimize stomach upset and nausea, ingest the tablet with food or milk. Follow the prescribed dosage and duration exactly, completing the full course of treatment. Consistent use, as directed by your physician, is crucial. Do not discontinue use without prior consultation. If also using antacids, separate Hikem tablet intake by at least four hours.
Patients using Hikem Tablets who experience symptoms consistent with COVID-19, including fever, dry cough, fatigue, or respiratory distress, must seek immediate medical attention. Their physician will determine the necessity of coronavirus testing and isolation, and all physician recommendations should be followed diligently.
The therapeutic impact of hydroxychloroquine may not be immediately apparent; symptom improvement for rheumatoid arthritis and similar autoimmune conditions might require several weeks or even months. Consistent medication adherence is crucial during this period. Bridge therapy with other drugs may be provided by your physician to manage symptoms in the meantime.
While infrequent, visual disturbances can occur with HCQS, particularly with prolonged use at elevated dosages (exceeding five years). These may manifest as difficulties with reading or visual perception (missing words, letters, or object parts), photosensitivity, blurred distance vision, and the perception of flashing or streaking lights. Immediate medical attention is warranted if any such symptoms arise. Your physician might conduct ophthalmological examinations to determine the necessity of halting Hikem Tablet administration. Regular eye exams may also be recommended for individuals receiving long-term HCQS prescriptions.
Prior to commencing HCQS therapy, an ophthalmological examination is mandatory, and subsequent examinations should be conducted annually. Regular monitoring of blood cell counts (CBC) and liver function (LFT) may also be recommended by your physician. Treatment with HCQS will be ceased if any irregularities are identified.
Hikem Tablet, an antimalarial drug, exhibits anti-inflammatory and immunomodulatory effects. It is distinct from steroids, opioids, and analgesics. In malaria, it eradicates the causative parasite. For rheumatoid arthritis, it alleviates joint inflammation and offers symptomatic relief.
Concurrent use of ibuprofen and hydroxychloroquine is acceptable; these medications don't demonstrably interact or impair each other's efficacy.
Discontinuing HCQS treatment prematurely, without physician consultation, may lead to disease exacerbation. Consequently, do not cease HCQS use unless advised by your doctor, regardless of perceived improvement in your condition.
Individuals with diabetes must exercise caution when taking HCQS. This medication can significantly reduce blood sugar, potentially causing severe hypoglycemia and loss of consciousness. Closely monitor blood glucose levels; if a drop occurs, seek immediate medical attention. Your physician may adjust your diabetic medication dosage based on your blood sugar readings.
Hydroxychloroquine (HCQS) can be taken, but ensure a minimum four-hour interval separates its administration from any antacid medication. Failure to observe this interval might hinder HCQS absorption and efficacy, potentially reducing its therapeutic effect.
Research on Hikem Tablet is ongoing, involving multiple human clinical trials to assess its potential for preventing novel coronavirus infection and treating COVID-19. Preclinical laboratory testing indicates some antiviral activity against the virus. Nevertheless, definitive proof of Hikem Tablet's efficacy against the novel coronavirus necessitates additional research.
India's COVID-19 task force, established by the ICMR, advises Hikem Tablet solely for coronavirus prevention within specific high-risk groups—individuals with elevated virus exposure risk or during emergencies. Prophylactic use is suggested for asymptomatic healthcare personnel treating suspected or confirmed COVID-19 patients and asymptomatic household members of positive cases.
We do not carry Hikem Tablets. If you believe you may have COVID-19, seek immediate medical attention and adhere to your physician's instructions. Do not use Hikem Tablets without a prescription from a licensed doctor. This medication requires a doctor's order.
Coronavir prevention with Hikem Tablets is limited to specified high-risk populations and urgent circumstances. Adherence to the physician's instructions regarding dosage, frequency, and treatment length is mandatory.
Hikem tablets are oral medications. To minimize stomach upset and nausea, consume them with food or milk. Adhere strictly to the prescribed dosage and duration, completing the entire course. Consistent use, as directed by your physician, is crucial. Discontinue use only after consulting your doctor. If you are also using antacids, separate Hikem tablet intake by at least four hours.
Patients taking Hikem Tablets who experience symptoms consistent with novel coronavirus infection—including fever, dry cough, fatigue, or shortness of breath—must seek immediate medical attention. Their physician will determine the need for COVID-19 testing and isolation, and all their recommendations should be followed carefully.
Hydroxychloroquine's therapeutic impact unfolds gradually. Symptom improvement in rheumatoid arthritis and similar autoimmune conditions might not become apparent for several weeks or even months. Consistent adherence to the prescribed dosage is crucial. Bridge therapy with supplementary medications may be provided by your physician to manage immediate symptom discomfort.
While infrequent, hydroxychloroquine (HCQS) can impact eyesight, particularly with higher dosages or prolonged use (exceeding five years). Visual disturbances such as difficulty reading or perceiving details (missing words, letters, or portions of objects), photosensitivity, blurred distance vision, and the appearance of light flashes or streaks may occur. Report any such symptoms to your physician promptly. They may perform ophthalmologic examinations and determine the necessity of ceasing Hikem Tablet administration. Regular eye exams might also be recommended for individuals prescribed HCQS.
Prior to commencing HCQS therapy, an ophthalmological examination is mandatory, and should be repeated annually. Periodic monitoring of complete blood counts (CBC) and liver function tests (LFTs) may also be recommended by your physician. Treatment with HCQS may be ceased if any irregularities are identified.
Hikem Tablet, an antimalarial drug, exhibits anti-inflammatory and immunomodulatory effects. This medication is not a steroid, opioid, or analgesic. Its mechanism in malaria involves eliminating the causative parasite. In rheumatoid arthritis, it alleviates joint inflammation, offering symptomatic relief.
Ibuprofen and HCQS can be taken concurrently; no clinically significant drug interactions are expected between them.
Discontinuing HCQS treatment prematurely, without physician guidance, could exacerbate your condition. Consequently, do not discontinue HCQS unless your doctor advises you to do so, regardless of any perceived improvement in symptoms.
Individuals with diabetes should exercise caution when taking HCQS, as it can significantly reduce blood sugar, potentially causing severe hypoglycemia and loss of consciousness. Regular blood glucose monitoring is crucial; if levels drop, immediate medical attention is necessary. Your physician may adjust your diabetes medication dosage based on your blood sugar readings.
Hydrochloroquine (HCQS) can be taken, but ensure a minimum four-hour interval between its administration and any antacid medication. Failure to observe this interval may compromise HCQS absorption and efficacy, potentially reducing its therapeutic effect.
Hikem Tablet
60
MRP 70
14% off